Document Detail

Low-molecular-weight heparin versus rivaroxaban in orthopedic surgery.
MedLine Citation:
PMID:  23547863     Owner:  NLM     Status:  In-Data-Review    
Evaluation of: Beyer-Westendorf J, Lützner J, Donath L et al. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery. Findings from the ORTHO-TEP registry. Thromb. Haemost. 109(1), 154-163 (2013). From the ORTHO-TEP registry on joint replacement arthroplasty (hip and knee) from Dresden, Germany, three periods of different prophylactic regimens have been compared. In the present paper, results from low-molecular-weight heparin and rivaroxaban have been analyzed, with rivaroxaban showing a benefit concerning both effect and side effects. Clinical end points are used, the results being in line with published data from randomized studies. Inclusion in the registry of consecutive patients is important to illustrate generalizability of results obtained in randomized trials. This review discusses the problem with using historical comparisons to draw firm conclusions.
David Bergqvist
Related Documents :
6837883 - One hundred consecutive carotid reconstructions: local versus general anesthesia.
24619293 - Effect of sleeve gastrectomy on gastroesophageal reflux.
17850413 - Predictive and protective factors associated with upper gastrointestinal bleeding after...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of hematology     Volume:  6     ISSN:  1747-4094     ISO Abbreviation:  Expert Rev Hematol     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-04-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101485942     Medline TA:  Expert Rev Hematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  135-7     Citation Subset:  IM    
Department of Surgery, Academic Hospital, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose...
Next Document:  Atypical lymphoid proliferations: the pathologist's viewpoint.